Fresenius Medical Care AG (FME)
FME · Health Care · 
Germany
Fresenius Medical Care AG (FME) is a German company in the Health Care sector. The stock has its largest weight in DBXD (DAX), at 0.47%. Anyone who holds an ETF containing Fresenius Medical Care also has an indirect stake in the company.
Data and Charts: Fresenius Medical Care
Key Data for Fresenius Medical Care
Alysly Data Analysis: Fresenius Medical Care
Fresenius Medical Care Connections
The map shows how Fresenius Medical Care connects to ETFs, indices and other names. Each link is based on measured data and is not a recommendation.
- Germany Country · domicile
- Health Care Sector · sector
- Bayer Stock · similar ETF exposure
- Fresenius Stock · similar ETF exposure
- Qiagen Stock · similar ETF exposure
- Siemens Healthineers Stock · similar ETF exposure
What ETF Is Fresenius Medical Care In?
Fresenius Medical Care has very high ETF coverage and is held by 31 of the 104 ETFs we track, which together follow 11 indices. That puts the stock in more ETFs than 99.0% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| DBXD / XDDA | DAX | 0.47% | €4.68 |
| EXS1 | DAX | 0.46% | €4.60 |
| ZPRE | MSCI EMU | 0.12% | €1.20 |
| XD5E | MSCI EMU | 0.11% | €1.15 |
| XEMU | MSCI EMU | 0.11% | €1.15 |
| SPFS | MSCI World Health Care | 0.10% | €0.97 |
| XDWH | MSCI World Health Care | 0.09% | €0.92 |
| XDEV | MSCI World Value | 0.09% | €0.85 |
| SPYE | MSCI Europe | 0.07% | €0.71 |
| X600 / XESU | STOXX Europe 600 | 0.06% | €0.62 |
| XMEU / XIEE | MSCI Europe | 0.06% | €0.61 |
| EXSA | STOXX Europe 600 | 0.06% | €0.60 |
| IMEA | MSCI Europe | 0.06% | €0.60 |
| XSX6 / XSX7 | STOXX Europe 600 | 0.06% | €0.60 |
| WVAL | MSCI World Value | 0.05% | €0.48 |
| EXUS / EXU1 | MSCI World ex USA | 0.03% | €0.35 |
| WIMI | MSCI World IMI | 0.01% | €0.13 |
| EUNL | MSCI World | 0.01% | €0.10 |
| IUSQ | MSCI ACWI | 0.01% | €0.10 |
| XDWD / XDWL | MSCI World | 0.01% | €0.10 |
| SPYY | MSCI ACWI | 0.01% | €0.07 |
| SWWD | MSCI World | 0.01% | €0.07 |
| SPPW | MSCI World | 0.01% | €0.07 |
| SPYI / SPSA | MSCI ACWI IMI | < 0.01% | < €0.05 |
The last column shows how much of €1,000 in one of these funds goes to Fresenius Medical Care, based on each fund's latest holdings list.
US-listed ETFs holding Fresenius Medical Care (weight per latest SEC filing): VXUS 0.02%. These funds are registered in the US; retail investors in the EU usually cannot buy them.
Fresenius Medical Care Weight in iShares Core MSCI World (EUNL) Since 2019
In iShares Core MSCI World (EUNL), Fresenius Medical Care had a weight of 0.04% on Sep 30, 2019 and 0.01% on Oct 30, 2026. The fund tracks the MSCI World. Its share peaked at 0.05% on Jun 30, 2020. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.
What's Inside Your ETF Portfolio and the ETF overlap check show how much Fresenius Medical Care overlaps with the rest of a portfolio.
Stocks With ETF Exposure Similar to Fresenius Medical Care
| Stock | Shared ETFs | r |
|---|---|---|
| Fresenius Medical Care | – | – |
 Fresenius | 31 | – |
| Qiagen | 31 | – |
 Siemens Healthineers | 30 | – |
 Bayer | 31 | – |
| Continental | 29 | – |
 Volkswagen Non-Voting Pref | 29 | – |
| Biomerieux | 27 | – |
| Koninklijke Philips N.V. | 27 | – |
These stocks reach a portfolio through largely the same funds as Fresenius Medical Care. “Shared ETFs” counts the funds that hold both.
Fundamental Analysis: Fresenius Medical Care
Latest Patents Granted to Fresenius Medical Care
In the 52 weekly issues of the US patent office from Nov 4, 2025 to Oct 27, 2026, Fresenius Medical Care received 71 utility patents and 4 design patents. That is 0.022% of all utility patents the US patent office granted in those weeks. The median time from filing to grant was 4.0 years.
| Granted | Patent | Title | Filed | Technology field |
|---|---|---|---|---|
| US 12776418 B2 | Medical device and computer-implemented method of predicting risk, occurrence or progression of adverse health conditions in test subjects in subpopulations arbitrarily selected from a total population | G16H Healthcare informatics | ||
| US 12766304 B2 | Closing element for a fluid line | A61M Human necessities | ||
| US 12766301 B2 | Infusion site of a blood tubing system | A61M Human necessities | ||
| US 12766233 B2 | Method of removing blood from an extracorporeal blood circuit, treatment apparatus, and tube system | A61M Human necessities | ||
| US 12766231 B2 | Dialysis machine | A61M Human necessities |
These are grants, not applications. The office usually publishes an application 18 months after the priority date; the grant tends to come much later. Owners counted: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH; Fresenius Medical Care Holdings, Inc. and FRESENIUS MEDICAL CARE AG. Titles as published by the office; median time based on 36 patents with a known filing date.
The patent screener lists more grants, filterable by company, type and technology field. The M&A and patents page compares companies.
